My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
December 2014
Patient Care and Science
CDC Warns of Drifted Influenza A H3N2 Viruses
As influenza season gets underway, the Centers for Disease Control and Prevention (CDC) issued an advisory regarding the potential for circulation of drifted influenza A viruses. The advisory was issued to re-emphasize the importance of the use of neuraminidase inhibitor antiviral medications when indicated for treatment and prevention of influenza, as an adjunct to vaccination.

IDSA offers two email services to help members stay informed of new drug approvals and similar updates from the Food and Drug Administration and CDC. Content includes a range of topics, including drug warnings, recalls, and outbreak investigations. Recent alerts have included:

Multistate Outbreak of Listeria Monocytogenes Infections Linked to Caramel Apples


FDA Approves Gardasil 9 for Prevention of HPV


Dietary Supplements Containing Live Bacteria or Yeast in Immunocompromised Persons: Warning - Risk of Invasive Fungal Disease

Fungal Contamination of Probiotic

IDSA members can sign up for these services online. (To subscribe, check the appropriate boxes to receive CDC’s Health Alert Network [HAN] messages and/or alerts from FDA, and provide your email address and name where indicated.)

Is Your Facility Experiencing Antibiotic Shortages?
IDSA members are urged to report drug shortages directly to FDA and to copy IDSA staff at schang@idsociety.org.



Next Article >

Post a comment

Your name:

Your comment:


Patient Care and Science
CDC Warns of Drifted Influenza A H3N2 Viruses
Clinical Practice Management
The Future of Telemedicine in ID
Policy and Advocacy
Fiscal Year 2015 Brings Stagnant Funding for ID, HIV
New Law to Incentivize Ebola Drug Development
Global ID
Science Speaks
Education and Resources
IDSA In-Training Exam is a Good Predicator of Performance on ID Certification Exam
IDSA Offers New MOC Modules on General ID and Infection Control
You and Your Colleagues
New Members
Top Stories
From the President: My Membership in IDSA is Part of My Identity as an ID Physician
Progress Continues on Several Antimicrobial Resistance Advocacy Fronts
IDSA Ebola Grants Still Available
Medical Scholars Program Applications Accepted Now Through February 2
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.